jpolicano

SalioGen Therapeutics Strengthens its Leadership Team to Advance its Gene Coding™ Platform

SalioGen Therapeutics Strengthens its Leadership Team to Advance its Gene Coding™ Platform CAMBRIDGE, Mass. – July 20, 2022 – SalioGen Therapeutics, a privately held biotechnology company developing Gene CodingTM, a new category of genetic medicine, today announced the expansion of its leadership team with the addition of five highly accomplished scientists, physicians and biotech industry […]

SalioGen Therapeutics Strengthens its Leadership Team to Advance its Gene Coding™ Platform Read More »

SalioGen Therapeutics Closes $115 Million Oversubscribed Series B Financing to Advance Gene CodingTM – A New Category of Genetic Medicine

SalioGen Therapeutics Closes $115 Million Oversubscribed Series B Financing to Advance Gene CodingTM – A New Category of Genetic Medicine CAMBRIDGE, Mass. – January 05, 2022 – SalioGen Therapeutics, a privately held biotechnology company developing Gene CodingTM, a new category of genetic medicine, today announced the completion of an oversubscribed and up-sized $115 million Series

SalioGen Therapeutics Closes $115 Million Oversubscribed Series B Financing to Advance Gene CodingTM – A New Category of Genetic Medicine Read More »

SalioGen Therapeutics Appoints Esteemed Industry Veterans to Executive Advisory Board

SalioGen Therapeutics Appoints Esteemed Industry Veterans to Executive Advisory Board John Maraganore, Ph.D., Mark McClellan, M.D., Ph.D. and Andrew Lo, Ph.D. appointed as Executive Advisors to support SalioGen’s efforts to realize the full potential of its novel Gene CodingTM platform CAMBRIDGE, Mass. – November 10, 2021 – SalioGen Therapeutics, a privately held biotechnology company developing

SalioGen Therapeutics Appoints Esteemed Industry Veterans to Executive Advisory Board Read More »

SalioGen Therapeutics Strengthens Management with Key Additions to Leadership Team to Advance Its Gene Coding Platform

SalioGen Therapeutics Strengthens Management with Key Additions to Leadership Team to Advance Its Gene Coding Platform Sung You, M.S., MBA, appointed as Chief Business and Strategy Officer Nancy L. Craig, Ph.D., appointed as Senior Vice President of Genetic Engineering and Mobile Elements Sandeep Nema, Ph.D., appointed as Senior Vice President of Technical Operations CAMBRIDGE, Mass.

SalioGen Therapeutics Strengthens Management with Key Additions to Leadership Team to Advance Its Gene Coding Platform Read More »